Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro KwikPen delivers a fixed, pre-set dose — the clicks you hear and feel during an injection are part of the pen's built-in delivery mechanism, not a way to adjust how much medicine you receive. The idea of counting clicks to microdose Mounjaro is a popular online theory, but it misunderstands how the pen is designed. Mounjaro is a prescription-only medicine, and any decision about dose should be made by the prescriber who reviewed your case, not by adjusting a pen at home. This page explains what the clicks on the KwikPen actually represent, why microdosing by click-counting is not a reliable method, and what to do if your prescribed dose isn't suiting you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is designed for simplicity and consistent delivery. You press the orange injection button, hold it down, and the pen clicks steadily as the plunger pushes the medicine through the needle. The Mounjaro SmPC on the eMC describes this as a normal part of injection technique, you hold until the clicking stops, then keep the pen in place for a further ten seconds before withdrawing.
Those clicks are the sound of the plunger advancing. They are not individual micrograms of tirzepatide. The number of clicks you hear can change based on how firmly you press the button, the angle of the pen, the resistance of your skin and subcutaneous tissue, and even ambient temperature. Two people injecting the same pen on the same day may count different numbers of clicks from an identical dose. That inconsistency matters enormously if someone is trying to stop the injection partway through to take a smaller amount.
The pen is not graduated like an insulin syringe. There is no dose window that changes as you inject. Once you press the button, the mechanism is designed to deliver the full pre-set dose. Stopping early by lifting the pen away mid-click means the remaining medicine stays in the pen, in the needle, or on the skin surface, none of which can be reliably quantified. You can read more about how the full injection process is supposed to work on our Mounjaro injection guide.
The concept appears frequently in online forums, often accompanied by a mounjaro microdosing chart listing a number of clicks per dose. The appeal is understandable. Some people find that their prescribed dose causes nausea or other gastrointestinal effects, particularly in the first week or two after a new pen. The instinct to take a smaller amount to ease the transition is a reasonable one. The problem is the method chosen.
No published trial (including the SURMOUNT-1 study involving thousands of adults, reported in the New England Journal of Medicine) tested click-counted microdosing as a titration strategy. The licensed titration schedule starts at 2.5 mg and increases in 4-week steps under prescriber guidance; that schedule exists specifically because it minimises side effects in most people. Attempting an informal, unvalidated sub-dose method at home bypasses that safety framework entirely.
There is also a practical inconsistency problem. Our page on how many clicks it takes to microdose Mounjaro explores this in detail, but the short answer is that no reliable figure exists, because the click count is not a fixed unit of volume. Any chart circulating online is based on approximations from individual users, not from Eli Lilly's engineering data. Using such a chart introduces meaningful uncertainty into a prescription medicine that requires consistent dosing to work safely.
This is the question behind most click-counting searches. If nausea, vomiting or other GI effects are making your current pen difficult to tolerate, there is a proper route: contact your prescriber. Dose modification, pausing a titration step, or staying on the current pen for longer than four weeks are all legitimate clinical tools. They are also safer than attempting an unmeasured partial injection.
At home, several things can reduce injection-related side effects without touching the dose. Injecting into the abdomen, thigh or upper arm (rotating the site each week) and ensuring the pen has had time to reach room temperature before use are both noted in patient guidance. Our guidance on using the KwikPen for repeat injections covers technique points that can make injections more comfortable.
If you are considering microdosing because you sourced a higher-strength pen than you were titrated to, that is a separate and more urgent conversation with a prescriber. Dose increases require clinical review, our clinical team at nume reviews each repeat order individually, which means dose changes are assessed before any new supply is dispatched. It is worth getting that input rather than improvising with the pen you already have.
For anyone weighing up the broader cost of switching providers or managing titration privately, our Mounjaro cost page sets out what private treatment typically includes and where hidden fees tend to arise.
For most people, 2.5 mg is already the lowest available dose in the licensed schedule, it exists precisely to let the body adjust, and the expectation is that the initial GI effects settle within a couple of weeks. If they do not, that is clinical information your prescriber needs.
Some patients ask whether splitting a 2.5 mg pen across two weeks (taking one injection a fortnight rather than weekly) is a better solution. This is occasionally discussed in specialist weight-management settings, but it is not part of the standard licensed schedule and would need explicit prescriber agreement. If you want to understand the technique involved before raising it with your prescriber, our guide on how to microdose a Mounjaro pen explains the mechanics and why the pen's design makes precise partial delivery so difficult.
The same applies to questions about microdosing the Mounjaro pen in a more general sense. The KB-aligned summary is consistent: there is no validated click-based method, the pen is not designed for partial delivery, and side-effect management belongs in a clinical conversation. If you are finding it hard to tolerate your current treatment, speaking to your prescriber is the right step, not a workaround that introduces dosing uncertainty into a medicine that your prescriber has personalised to your case.
If you are not yet being seen by a prescriber and want a clinical review of whether Mounjaro is right for you, you can speak to our prescribers through a free consultation. A named clinician reads every response the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.